In 2023, it is anticipated that the Triptorelin Market will be worth roughly US$ 955.50 million. From 2023 to 2033, the industry is expected to grow at a 5% CAGR, driven by the increased prevalence of endometriosis among females around the world. The triptorelin market is anticipated to produce US$ 1556.41 million by 2033. Salivary …
Category Archives: Healthcare Trends
Hyperinsulinemia Hypoglycaemia Treatment Market is anticipated to reach US$ 179.08 Million by 2033, growing at a CAGR of 6% from 2023 to 2033
According to FMI, the Hyperinsulinemia Hypoglycaemia Treatment Market is foreseen to rise to US$ 100 million in FY 2023, representing a Y-o-Y increase of over 4%. Across the forecast period ranging from 2023 to 2033, the industry is likely to gain traction at a CAGR of 6%, reaching a market value of US$ 179.08 million …
Predictive Disease Analytics Market: Empowering Healthcare Providers to Revolutionize Patient Care With 22.5% CAGR Growth | FMI
The global Predictive Disease Analytics Market is predicted to register a CAGR of 22.5% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 2.45 billion in 2023 to US$ 18.64 billion by 2033 end. The demand for predictive disease analytics is expected to increase owing to the …
Growing Prevalence Of Neurological And Chronic Pain Conditions Fueling Demand For Gabapentin Market To US$ 3.54 Billion By 2033 | FMI
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applications and increasing recognition as …
Vitamin D Testing Market to Witness Luminous Growth in the Coming Decade, Reaching US$ 1,999.35 Million By 2033, Propelled By 8.1% CAGR
The Vitamin D Testing Market refers to the industry involved in the development, manufacturing, and distribution of tests used to measure the levels of vitamin D in the human body. Vitamin D is an essential nutrient that plays a crucial role in bone health, immune function, and various other physiological processes. Vitamin D testing is …
Nutraceutical Contract Manufacturing Services Market to Embark On a Technological Journey to Reach US$ 466.11 Billion by 2033, According To FMI
The global Nutraceutical Contract Manufacturing Services Market is poised to attain remarkable growth from 2023 to 2033. According to the research report published by FMI, the global market is projected to cross a valuation of US$ 149.41 billion in 2023. It is likely to reach a valuation of US$ 466.11 billion by 2033. The market …
Antimicrobial Wound Care Dressings Market to Grow At 6.4% CAGR by 2033, Driven By the Expanding Presence of Wound Care Management Manufacturers in Hospitals | FMI
The global Antimicrobial Wound Care Dressings Market is expected to be worth US$ 1.38 billion in 2023, with a CAGR of 6.4% from 2023 to 2033. By 2033, the global market is set to reach US$ 2.57 billion. Antimicrobial wound care dressings function as a barrier against germs that may enter the wound and cause …
Global Live Cell Encapsulation Market is Poised for Impressive Growth in the Coming Years, With FMI Research Forecasting a Value of US$ 323.33 Million By 2033
The industry that deals with the creation, manufacturing, and marketing of tools and products for the encapsulation of live cells is known as the “Live Cell Encapsulation Market” To improve living cells’ survival, functionality, and therapeutic effectiveness, live cells are enclosed within a barrier or matrix that provides protection. Techniques for encapsulating cells can give …
In-Depth Analysis by FMI: Animal Healthcare Market to Grow Steadily at 4.3% CAGR, Anticipates US$ 62.3 Billion by 2033
Anticipated to be valued at US$ 40.9 billion in 2023, the animal healthcare market is set to witness remarkable growth, reaching an estimated US$ 62.3 billion by 2033. This upward trajectory is underpinned by a substantial compound annual growth rate (CAGR) of 4.3% throughout the forecast period. Several factors are driving the burgeoning demand for …
Insights from FMI: Dengue Vaccines Market to Maintain 12.9% CAGR, Reaching US$ 1603.7 Million by 2033
The dengue vaccines market is poised for robust expansion, with a projected total valuation set to reach US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is on the rise, with a projected Compound Annual Growth Rate (CAGR) of 12.9% in sales volume (units). Dengue vaccine development has reached a pivotal stage in its …